Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy

Canadian Journal of Cardiology

Volumn 25, Issue 2, 2009, Pages

  Breton, Robert ^a   Mathieu, Jean ^b,c  

^a CHICOUTIMI HOSPITAL   (Canada)

^b Neuromuscular Clinic   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Electrocardiography; Epidemiology; Mortality; Pacemarkers; Sudden death

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR DISEASE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; NON INVASIVE MEASUREMENT; PR INTERVAL; PREDICTION; PRESCHOOL CHILD; QRS COMPLEX; QT INTERVAL; RISK ASSESSMENT; SCHOOL CHILD; SICK SINUS SYNDROME; SUDDEN DEATH; SURVIVAL RATE; ANALYSIS OF VARIANCE; COHORT ANALYSIS; CONFIDENCE INTERVAL; HEART ARRHYTHMIA; HEART BLOCK; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 63049114007     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70479-9     Document Type: Article

References (42)

1. Mathieu J, DeBraekeleer M, Prévost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990;40:839-42.
2. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-6.
3. Harper PS. Myotonic Dystrophy, 2nd edn. London: WB Saunders, 1989.
4. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Belloci F. Myotonic dystrophy and the heart. Heart 2002;88:665-70.
5. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22.
6. Finsterer J, Stöllberger C, Blazek G, Spahits E. Cardiac involvement in myotonic dystrophy, Becker muscular dystrophy and mitochondrial myopathy: A five-year follow-up. Can J Cardiol 2001;10:1061-9.
7. De Ambroggi L, Raisaro A, Marchiano V, Radice S, Meola G. Cardiac involvement in patients with myotonic dystrophy: Characteristic features of magnetic resonance imaging. Eur Heart J 1995;16:1007-10.
8. Vignaux O, Lazarus A, Varin J, et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: Initial results. Radiology 2002;224:231-5.
9. Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type 1. Am Heart J 2004;147:224-7.
10. Mathieu J, Allard P, Potvin L, Prévost C, Bégin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-62.
11. deDie-Smulders CEM, Höweler CJ, Thijs C, et al. Age and causes of death in adult onset myotonic. dystrophy. Brain 1998;121:1557-63.
12. Merino JL, Carmona JR, Fernandez-Lozano I, Peinado R, Basrerra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy. Circulation 1998;98:541-6.
13. Grigg LE, Chan W, Mond HG, Vbbra JK, Downey WF. Ventricular tachycardia and sudden death in myotonic dystrophy, electrophysiologic and pathologic features. J Am Coll Cardiol 1995;6:254-6.
14. Cannom DS, Wyman GM, Goldreyer BN. Clinical and induced ventricular tachycardia in myotonic dystrophy. J Am Coll Cardiol 1984;4:625-8.
15. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-52.
16. Mammarella A, Paradiso M, Antonini G, et al. Natural history of cardiac involvement in myotonic dystrophy (Steinert's disease): A 13-year follow-up study. Adv Ther 2000;17:238-51.
17. Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-6.
18. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 corelates with age and CTG repeat length. J Cardiovasc Electrophysiol 2002;13:444-8.
19. Nishioka SA, Martinelli Filho M, Marie S, Zatz M, Costa R. Myotonic dystrophy and heart disease: Behavior of arrhythmic events and conduction disturbances. Arq Bras Cardiol 2005;84:330-6. (Abst)
20. Chebel S, Ben Hamda K, Boughammoura A, Frith Ayed M, Ben Farhat MH. Cardiac involvement in Steinert's myotonic dystrophy. Rev Neurol (Paris) 2005;161:932-9.
21. Colleran JA, Hawley RJ, Pinnow EE, Kokkinos PF, Fletcher RD. Value of the electrocardiogram in determining cardiac events and mortality in myoonic dystrophy. Am J Cardiol 1997;80:1494-7.
22. Babuty D, Fauchier L, Tena-Carbi D, et al. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? Heart 1999;82:634-7.
23. Babuty D, Fauchier L, Tena-Carbi D, et al. Significance of late potentials in myotonic dystrophy. Am J Cardiol 1999;84:1099-101.
24. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th edn. Philadelphia: Elsevier Saunders, 2005:65-8.
25. Sabovic M, Medica I, Logar N, Mandic E, Zidar J, Peterlin B. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden dead, in patients with myotonic dystrophy. Neuromuscul Disord 2003;13:822-6.
26. Mathieu J, DeBraekeleer M, Prévost C, Boily C. Myotonic dystrophy: Clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology 1992;42:203-8.1
27. Bégin P, Mathieu J, Almirall J, Grassino A. Relationship between chronic hypercapnia and inspiratory muscle weakness in myotonic. dystrophy. Am J Resp Crit Care Med 1997;156:133-9.
28. Mathieu J, Boivin P, Meunier D, Gaudreault M, Bégin P. Assessment of a disease-specific impairment rating scale in myotgnic dystrophy. Neurology 2001;56:336-40.
29. Brisson D, Tremblay M, Pr6vost C, Laberge C, Puymirat J, Mathieu J. Sibship stability of genotype and phenotype in myotonic dystrophy. Clin Genet 2002;62:220,5.
30. Mathieu J, Boivin H, Richards CL. Quantitative motor assessment in myotonic dystrophy. Can J Neurol Sci 2003;30:129-36.
31. Laberge L, Bégin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004;13:95-100.
32. Arsenault ME, Prévost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006;66:1248-50.
33. Laberge L, Veillette S, Mathieu J, Auclair J, Perron M. The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet 2007;71:59-66.
34. Antonini G, Giubilei F, Mammarella A, et al. Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats. Neurology 2000;55:1207-9.
35. Clarke NRA, Kellion AD, Nixon J, Hilton-Jones P, Forfar JC. Does cytosine-thymine-guaiiine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 2001;86:411-6.
36. Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W. Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol 2002;249:693-8.
37. Melacini P, Villanova C, Menegazzo E, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995;25:239-45.
38. Finsterer J, Gharehbaghi-Schnell E, Stollberger C, Fheodoroff K, Seiser A. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 2001;59:350-5.
39. Hardin BA, Lowe MR, Bhakta D, Groh WJ. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol 2003;8:227-32.
40. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. Circulation 2002;106:2145-61.
41. Hawley RJ, Colleran JA, Fletcher R, et al. Indications for cardiac pacemaker implantation in myotonic dystrophy. MedGenMed 1999;Sept 7:E5.
42. Bushby K, Muntoni F, Bourke JP. 107th ENMC International Workshop: The management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003;13:166-72.